• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广义多维动态分配方法。

Generalized multidimensional dynamic allocation method.

机构信息

Medidata Solutions, New York, NY 10003, USA.

出版信息

Stat Med. 2012 Dec 10;31(28):3537-44. doi: 10.1002/sim.5418. Epub 2012 Jun 27.

DOI:10.1002/sim.5418
PMID:22736449
Abstract

Dynamic allocation has received considerable attention since it was first proposed in the 1970s as an alternative means of allocating treatments in clinical trials which helps to secure the balance of prognostic factors across treatment groups. The purpose of this paper is to present a generalized multidimensional dynamic allocation method that simultaneously balances treatment assignments at three key levels: within the overall study, within each level of each prognostic factor, and within each stratum, that is, combination of levels of different factors Further it offers capabilities for unbalanced and adaptive designs for trials. The treatment balancing performance of the proposed method is investigated through simulations which compare multidimensional dynamic allocation with traditional stratified block randomization and the Pocock-Simon method. On the basis of these results, we conclude that this generalized multidimensional dynamic allocation method is an improvement over conventional dynamic allocation methods and is flexible enough to be applied for most trial settings including Phases I, II and III trials.

摘要

动态分配自 20 世纪 70 年代首次提出以来,一直受到广泛关注,它是一种在临床试验中分配治疗方法的替代手段,有助于在治疗组之间平衡预后因素。本文旨在提出一种广义多维动态分配方法,该方法可同时在三个关键层次上平衡治疗分配:整个研究中、每个预后因素的每个层次内以及每个层内,即不同因素水平的组合。此外,它还为试验提供了不平衡和自适应设计的能力。通过比较多维动态分配与传统分层区组随机化和 Pocock-Simon 方法的模拟,研究了所提出方法的治疗平衡性能。基于这些结果,我们得出结论,这种广义多维动态分配方法优于传统的动态分配方法,并且足够灵活,可以应用于大多数试验设置,包括 I 期、II 期和 III 期试验。

相似文献

1
Generalized multidimensional dynamic allocation method.广义多维动态分配方法。
Stat Med. 2012 Dec 10;31(28):3537-44. doi: 10.1002/sim.5418. Epub 2012 Jun 27.
2
[Treatment by drawing lots in a therapeutic trial with a balance distribution of prognostic factors: the minimization method].[在预后因素均衡分布的治疗试验中通过抽签进行治疗:最小化法]
Rev Epidemiol Sante Publique. 1988;36(2):138-43.
3
A treatment allocation procedure for sequential clinical trials.一种用于序贯临床试验的治疗分配程序。
Biometrics. 1980 Mar;36(1):81-90.
4
Randomization by minimization for unbalanced treatment allocation.最小化随机分组法用于不均衡治疗分配。
Stat Med. 2009 Nov 30;28(27):3329-46. doi: 10.1002/sim.3710.
5
A simulation study of the validity and efficiency of design-adaptive allocation to two groups in the regression situation.回归情形下两组设计自适应分配的有效性和效率的模拟研究。
Int J Biostat. 2009 May 29;5(1):Article 19. doi: 10.2202/1557-4679.1144.
6
A generic minimization random allocation and blinding system on web.一种基于网络的通用最小化随机分配与盲法系统。
J Biomed Inform. 2006 Dec;39(6):706-19. doi: 10.1016/j.jbi.2006.02.015. Epub 2006 Feb 28.
7
Designing for cancer clinical trials: selection of prognostic factors.癌症临床试验设计:预后因素的选择
Cancer Treat Rep. 1980 Feb-Mar;64(2-3):499-502.
8
Treatment allocation for nonlinear models in clinical trials: the logistic model.临床试验中非线性模型的治疗分配:逻辑模型
Biometrics. 1984 Jun;40(2):409-20.
9
Weighted re-randomization tests for minimization with unbalanced allocation.用于不平衡分配最小化的加权重新随机化检验。
Pharm Stat. 2013 Jul-Aug;12(4):243-53. doi: 10.1002/pst.1577. Epub 2013 Jun 13.
10
Flexible two-stage design with sample size reassessment for survival trials.用于生存试验的具有样本量重新评估的灵活两阶段设计。
Stat Med. 2007 Nov 30;26(27):5002-13. doi: 10.1002/sim.2966.

引用本文的文献

1
Find your rhythm and regulate: Breath-synced vibration feedback during breath-focused mindfulness reduces respiration variability in trauma-exposed adults.找到你的节奏并进行调节:在专注于呼吸的正念训练中,呼吸同步振动反馈可降低受过创伤的成年人的呼吸变异性。
J Anxiety Disord. 2025 Jun;112:103008. doi: 10.1016/j.janxdis.2025.103008. Epub 2025 Mar 23.
2
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.非布司他预防接受化疗的恶性肿瘤患者肿瘤溶解综合征的疗效和安全性:一项比较非布司他与别嘌醇的III期随机多中心试验。
Int J Clin Oncol. 2016 Oct;21(5):996-1003. doi: 10.1007/s10147-016-0971-3. Epub 2016 Mar 26.